Home > Insider Trading > Filing (0001654954-19-006225)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1410098	Cormedix Inc.	CRMD	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1489798	Janet Dillione	C/O Cormedix Inc. 400 Connell Drive, Suite 5000 Berkeley Heights NJ 07922		No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-05-15	11,144	$6.74	47,326	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Phantom Stock	Acquisiton	2019-05-15	1,126	$0.00	226	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
226			No	4	A	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Phantom Stock	$0.00		843	843	Direct
Common Stock	Stock Option (Right to Buy Common Stock)	$8.30	2029-01-10	15,000	15,000	Direct
Common Stock	Phantom Stock	$0.00		1,328	1,328	Direct
Common Stock	Phantom Stock	$0.00		2,728	2,728	Direct
Common Stock	Phantom Stock	$0.00		7,500	7,500	Direct
Common Stock	Stock Option (Right to Buy Common Stock)	$2.85	2028-02-16	8,000	8,000	Direct
Common Stock	Phantom Stock	$0.00		2,679	2,769	Direct
Common Stock	Phantom Stock	$0.00		3,125	3,125	Direct
Common Stock	Phantom Stock	$0.00		4,167	4,167	Direct
Common Stock	Stock Option (Right to Buy Common Stock)	$11.20	2027-02-21	8,000	8,000	Direct
Common Stock	Phantom Stock	$0.00		695	695	Direct
Common Stock	Phantom Stock	$0.00		829	829	Direct
Common Stock	Stock Option (Right to Buy Common Stock)	$15.15	2025-08-11	10,000	10,000	Direct
Common Stock	Phantom Stock	$0.00		283	283	Direct
Common Stock	Stock Option (Right to Buy Common Stock)	$15.15	2026-02-21	19,000	19,000	Direct
Common Stock	Phantom Stock	$0.00		767	767	Direct
Common Stock	Phantom Stock	$0.00		554	554	Direct
Common Stock	Phantom Stock	$0.00		867	867	Direct
Common Stock	Phantom Stock	$0.00		3,062	3,062	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
	843	843	Direct
2029-01-10	15,000	15,000	Direct
	1,328	1,328	Direct
	2,728	2,728	Direct
	7,500	7,500	Direct
2028-02-16	8,000	8,000	Direct
	2,679	2,769	Direct
	3,125	3,125	Direct
	4,167	4,167	Direct
2027-02-21	8,000	8,000	Direct
	695	695	Direct
	829	829	Direct
2025-08-11	10,000	10,000	Direct
	283	283	Direct
2026-02-21	19,000	19,000	Direct
	767	767	Direct
	554	554	Direct
	867	867	Direct
	3,062	3,062	Direct

Footnotes

Represents the weighted average purchase price of the shares purchased from a low of $6.72 to a high of $6.74 per share.
Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director.
These options were granted on 01/10/2019. The options vest monthly with 100% vesting on the one year anniversary of the date of grant, subject to continued service on the board.
These options were granted on 2/16/2018. The options vest in full on the first anniversary of the date of grant, subject to continued service on the board.
These options were granted on 2/21/2017. The options vest in full on the first anniversary of the date of grant, subject to continued service on the board.
These options were granted on 8/12/2015. The options vest as follows: 1/3 on 8/12/2015, 1/3 on 8/12/2016, and 1/3 on 8/12/2017.
These options were granted on 2/21/2016. These options vest in full on the first anniversary of the date of grant, subject to continued service on the board.
The issuer effected a 1-for-5 reverse stock split on March 26, 2019. All share and per share amounts shown in this Form 4 have been adjusted to reflect the reverse stock split.